Home » » Cipla to conduct study on Paxlovid https://ift.tt/nVY50um

Cipla to conduct study on Paxlovid https://ift.tt/nVY50um

No comments
In its meeting held this week, the SEC granted approval to the company to conduct bioavailability and bio equivalence (BA/BE) studies. “Cipla will carry study on 44 participants and soon share data with the regulatory authority,” a government official said.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/dwH3NGJ
Share:

No comments:

Post a Comment

Search This Blog
Powered by Blogger.

Labels

Unordered List

  • Lorem ipsum dolor sit amet, consectetuer adipiscing elit.
  • Aliquam tincidunt mauris eu risus.
  • Vestibulum auctor dapibus neque.

Pages

Theme Support

Need our help to upload or customize this blogger template? Contact me with details about the theme customization you need.